Xiao Rong, Sorensen Tanya K, Frederick Ihunnaya O, El-Bastawissi Amira, King Irena B, Leisenring Wendy M, Williams Michelle A
Center for Perinatal Studies, Swedish Medical Center, Seattle, WA 98122, USA.
Paediatr Perinat Epidemiol. 2002 Oct;16(4):297-304. doi: 10.1046/j.1365-3016.2002.00448.x.
We studied the relationship between maternal second-trimester serum ferritin concentrations and preterm delivery. The 312 preterm delivery cases, studied in aggregate and in subgroups [spontaneous preterm labour, preterm premature rupture of membranes, medically induced preterm delivery, moderate preterm delivery (gestational age at delivery 34-36 weeks) and very preterm delivery (gestational age at delivery <34 weeks)] were compared with 424 randomly selected women who delivered at term. Maternal ferritin concentrations, measured in serum collected at 17 weeks gestation on average, was determined using a two-site chemiluminometric immunoassay. Using multiple logistic regression, we derived maximum likelihood estimates of adjusted odds ratios (OR) and 95% confidence intervals [CI]. Elevation in maternal second-trimester ferritin was weakly associated with the risk of preterm delivery overall. After adjusting for possible confounding by maternal age, race/ethnicity, parity, Medicaid payment status and smoking during the index pregnancy, the OR for extreme quartiles (>64.5 vs. <26.0 ng/mL) of ferritin was 1.3 [95% CI 0.8, 2.1]. Stratified analyses indicated that elevated maternal serum ferritin was associated with an increased risk of preterm premature rupture of membranes (OR = 2.1; 95% CI 1.1, 4.1), but not with spontaneous preterm labour (OR = 0.9; 95% CI 0.4, 1.7) or medically induced preterm delivery (OR = 1.1; 95% CI 0.6, 2.0). The relationship between elevated maternal second-trimester serum ferritin concentrations and preterm delivery was strongest for spontaneous very preterm deliveries (<34 weeks gestation). Women with ferritin concentrations in the highest decile (>96 ng/mL) experienced a 2.7-fold increased risk of delivering before 34 completed weeks, compared with women with concentrations <26.0 ng/mL. These results are consistent with some previous reports, and further underline the potential for heterogeneity in the aetiology of preterm delivery.
我们研究了孕中期母体血清铁蛋白浓度与早产之间的关系。将312例早产病例(整体及按亚组分析,包括自发性早产、胎膜早破早产、医源性早产、中度早产(分娩孕周为34 - 36周)和极早早产(分娩孕周<34周))与424例随机选取的足月分娩女性进行比较。母体铁蛋白浓度通过平均在妊娠17周时采集的血清进行测定,采用双位点化学发光免疫分析法。使用多因素逻辑回归,我们得出了调整后的比值比(OR)的最大似然估计值及95%置信区间(CI)。总体而言,孕中期母体铁蛋白升高与早产风险的关联较弱。在对母体年龄、种族/族裔、产次、医疗补助支付状况及本次妊娠期间吸烟等可能的混杂因素进行调整后,铁蛋白极端四分位数(>64.5 vs. <26.0 ng/mL)的OR为1.3 [95% CI 0.8, 2.1]。分层分析表明,母体血清铁蛋白升高与胎膜早破早产风险增加相关(OR = 2.1;95% CI 1.1, 4.1),但与自发性早产(OR = 0.9;95% CI 0.4, 1.7)或医源性早产(OR = 1.1;95% CI 0.6, 2.0)无关。孕中期母体血清铁蛋白浓度升高与早产之间的关系在自发性极早早产(孕周<34周)中最为显著。与铁蛋白浓度<26.0 ng/mL的女性相比,铁蛋白浓度处于最高十分位数(>96 ng/mL)的女性在妊娠34周前分娩的风险增加了2.7倍。这些结果与之前的一些报告一致,并进一步强调了早产病因存在异质性的可能性。